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Abstract Comparative molecular field analysis (CoM-
FA) and comparative molecular similarity indices analysis
(CoMSIA) based on three-dimensional quantitative struc-
ture–activity relationship (3D-QSAR) studies were con-
ducted on a series (39 molecules) of peptidyl vinyl sulfone
derivatives as potential Plasmodium Falciparum cysteine
proteases inhibitors. Two different methods of alignment
were employed: (i) a receptor-docked alignment derived
from the structure-based docking algorithm GOLD and (ii)
a ligand-based alignment using the structure of one of the
ligands derived from a crystal structure from the PDB
databank. The best predictions were obtained for the
receptor-docked alignment with a CoMFA standard model
(q2 = 0.696 and r2 = 0.980) and with CoMSIA combined
electrostatic, and hydrophobic fields (q2 = 0.711 and
r
2
= 0.992). Both models were validated by a test set of
nine compounds and gave satisfactory predictive r2pred
values of 0.76 and 0.74, respectively. CoMFA and CoM-
SIA contour maps were used to identify critical regions
where any change in the steric, electrostatic, and hydro-
phobic fields may affect the inhibitory activity, and to
highlight the key structural features required for biological
activity. Moreover, the results obtained from 3D-QSAR
analyses were superimposed on the Plasmodium Falcipa-
rum cysteine proteases active site and the main interactions
were studied. The present work provides extremely useful
guidelines for future structural modifications of this class
of compounds towards the development of superior
antimalarials.
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Introduction
The history of malaria treatment is one of acquired drug
resistance and toxic side effects. There is known, wide-
spread resistance to once highly effective but now virtually
useless antimalarials, like the well-known example of
chloroquine [1–3]. The increasing resistance of malaria
parasites is a key factor in the persistence of malaria as a
global major health concern [4]. Therefore, novel, less
toxic, and more specific inhibitors are urgently needed to
control this infectious disease. Potential biochemical tar-
gets for antimalarial development have been identified after
the unveiling of the Plasmodium falciparum (Pf) genome
in 2002 [5, 6]. Among them, there is particular emphasis on
proteases having key roles on the degradation of host’s
hemoglobin within the food vacuole of blood-stage para-
sites, as these depend on such process for their survival.
Among such enzymes, the cysteine proteases, Falcipain-2
(FP2) and Falcipain-3 (FP3), are highly promising anti-
malarial drug targets [7–10].
Cysteine proteases were given this name due to the
function of a catalytic cysteine. This amino acid catalyzes
protein hydrolysis via nucleophilic attack to the carbonyl
carbon of a susceptible bond. FP2 and FP3 are the best
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characterized cysteine proteases of the malaria parasite and
are fairly typical papain-family (clan CA) cysteine proteases
[7]. Over the past years the development of small molecule
inhibitors against Pf falcipains has received a lot of attention
by both the pharmaceutical industry and the medicinal
chemistry community. Indeed, most studies in this area have
shown that falcipain inhibitors prevent hemoglobin hydro-
lysis, block parasite development and cure murine malaria
[11–13]. Moreover, the combination of high-throughput
screening, molecular modeling methods and the availability
of X-ray structures of falcipains has contributed to the dis-
covery of potent inhibitors able to inactivate these Pf
enzymes in a reversible or irreversible manner [7, 14].
In 1996, Rosenthal and colleagues evaluated the anti-
malarial effects of a series of vinyl sulfones as cysteine
proteases inhibitors [12]. These organic compounds tend to
covalently bind to the enzymes by an irreversible addition of
the thiol group of the catalytic cysteine to the electrophilic
vinyl sulfone moiety, which behaves as a Michael acceptor.
The study revealed that some compounds of this family were
shown to be nontoxic, active against Pf falcipains and
exhibited antiparasitic activity. Several vinyl sulfones pre-
sented nanomolar activities and the compound Mu-Leu-
hPh-VSPh (also named K11017, Fig. 1) was the one that
most effectively inhibited falcipains, blocked hemoglobin
degradation and parasite development. To increase both
bioavailability and aqueous solubility, several structural
replacements on K11017 were tested [15]. Although some
compounds demonstrated better activities than the parent
molecule, they also revealed limited utility as therapeutic
agents due to their susceptibility to protease degradation and
their poor absorption through cell membrane [14]. In an
effort to well define the structure–activity relationships of
this class of compounds, Shenai et al. recently disclosed a
new series of 39 new vinyl sulfone, vinyl sulfonate ester, and
vinyl sulfonamide cysteine protease inhibitors and deter-
mined their FP2 inhibitory activity [16].
This previous experimental structure–activity study of
vinyl sulfones as FP inhibitors motivated us to engage in a
complementary computational 3D-QSAR analysis, along
with docking studies, of the same set of 39 peptidyl vinyl
sulfone derivatives. This dataset was analyzed in an effort
to: (i) derive a statistically significant and predictive model
of peptidyl vinyl sulfones affinity towards the FP2 cysteine
protease and (ii) identify the physicochemical properties
that have a substantial effect on the binding affinity of
those ligands. The knowledge of the protein structure is not
a pre-requisite to perform QSAR analysis. However,
combining docking and 3D-QSAR analysis is advanta-
geous because it allows the direct visualization and inter-
pretation of the results obtained by the derived models with
respect to the protein environment. This information pro-
vided valuable insight into structure activity interpretations
by revealing the interactions contributing positively or
negatively to the binding affinity.
Computational methods
Inhibitor data set and ligand preparation
The set of 39 peptidyl vinyl sulfones (Fig. 2) with Pf FP2
inhibitory activity was identified from the literature [16].
All inhibitors were synthesized in the same laboratory and
the activity data, reported as IC50, were determined using
the same assay protocol [12]. This aspect is crucial since
homogeneity of experimental conditions is required to get
reliable 3D-QSAR models. The IC50 value of each inhib-
itor was converted into pIC50 (-log IC50) in order to use
the data as a dependent variable in the CoMFA and
CoMSIA models. The structures, drawn with Marvin-
Sketch [17], and inhibitory activities (IC50 and pIC50) of
the studied compounds are displayed in Table 1.
The 3D structures of the small organic molecules were
built based on the docked structure of K11017 (ligand 14),
within the FP2 catalytic site. The molecular structures of
the inhibitors were generated employing the Tripos force
field within the Sybyl X 1.3 molecular modeling program
[18]. Charges were assigned using the Gasteiger-Marsili
method. Energy minimization was performed using 20
simplex iterations followed by 1,000 steps of Powell
Fig. 1 Structure of vinyl sulfone, Mu-Leu-hPh-VSPh (or K11017) Fig. 2 General structure of peptidyl vinyl sulfone derivatives
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minimization until achieving the gradient norm of
0.05 kcal/mol.
Molecular docking
As no experimental FP2 structure bound to a peptidyl vinyl
sulfone inhibitor is available, docking calculations were
conducted to predict the appropriate binding orientation of
the ligands, into the FP2 catalytic site. For this process, we
used the molecular docking program GOLD (Genetic
Optimization for Ligand Docking) [19, 20] from the
Cambridge Crystallographic Data Center.
The X-ray structure of FP2 with its bound inhibitor E64
(PDB code: 3BPF) [21] was used and prepared for docking
with Sybyl X 1.3 software. The original ligand, ions and
solvent molecules were removed and the protein was pro-
tonated to a pH = 5.5. The protein was then minimized
with the AMBER program [22] by 500 steps of steepest
descent followed by 2,000 steps of conjugate gradient to
remove bad contacts using a generalized-Born solvent
model. The biomolecular force field ff03 was used [23].
For docking studies the genetic operations were set to
default parameters with a population size of 100
Table 1 Structures, experimental FP2 activities (IC50 and pIC50),
predicted activities (Calcd) and residuals (Res) by CoMFA and
CoMSIA models of peptidyl vinyl sulfone derivatives. Compounds
marked with * belong to the test set
 ID R3 R5/R4
FP2 
IC50
(nM)
pIC50
CoMFA CoMSIA 
Calcd Res Calcd Res 
1 CH2 110 6.959 7.030 0.071 6.947 0.012
2* CH2 120 6.921 7.067 0.146 7.235 0.314
3 CH2 71 7.149 7.084 0.065 7.065 0.084
4 CH2 120 6.921 6.774 0.147 6.984 0.063
5 O 120 6.921 6.790 0.131 6.859 0.062
6 O 56 7.252 7.247 0.005 7.256 0.004
7 O 290 6.538 6.655 0.117 6.588 0.050
8* O 230 6.638 7.235 0.597 6.483 0.155
9 O 130 6.886 6.889 0.003 6.859 0.027
10 35 7.456 7.487 0.031 7.479 0.023
11* 27 7.569 7.996 0.427 7.865 0.296
12 8.7 8.060 7.936 0.124 7.900 0.160
13 9.2 8.036 8.232 0.196 8.096 0.060
14 3.5 8.456 8.456 0.000 8.392 0.064
15 6.9 8.161 8.337 0.176 8.311 0.150
16 9.9 8.004 7.941 0.063 8.053 0.049
17 6.7 8.174 8.028 0.146 8.169 0.005
18* 140 6.854 7.480 0.626 7.578 0.724
Table 1 continued
21 25 7.602 7.711 0.109 7.594 0.008
22 14 7.854 7.981 0.127 7.898 0.044
23* 16 7.796 7.681 0.115 7.810 0.014
24 3.6 8.444 8.460 0.016 8.375 0.069
25 2.5 8.602 8.562 0.040 8.583 0.019
26 2.2 8.658 8.733 0.075 8.643 0.015
27 16 7.796 7.796 0.000 7.746 0.050
28 OMe 0.7 9.155 9.198 0.043 9.153 0.002
29* OMe 1.9 8.721 8.862 0.141 8.798 0.077
30 OMe 0.9 9.046 9.183 0.137 8.967 0.079
31 F 0.7 9.155 9.045 0.110 9.114 0.041
32 F 21 7.678 7.797 0.119 7.828 0.150
33 F 0.9 9.046 8.809 0.237 9.055 0.009
34* H 0.7 9.155 8.918 0.237 8.943 0.212
35 H 350 6.456 --- --- --- --- 
36 H 0.7 9.155 9.109 0.046 9.131 0.024
37 H 0.8 9.097 8.896 0.201 9.197 0.100
38* F 0.9 9.046 8.279 0.767 8.122 0.924
39 OMe 0.9 9.046 9.076 0.030 8.956 0.090
19* 2.3 8.638 8.091 0.547 7.985 0.653
20 2.2 8.658 8.717 0.059 8.765 0.107
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individuals. The selection pressure was set at 1.1 and
default operator weights were used for crossover, mutation
and migration, i.e., 95, 95 and 10, respectively. The bind-
ing site was defined as 15 A˚ radius from the catalytic amino
acid Cys42 and the GoldScore function was used to rank
the different binding poses.
Previously, the docking protocol was tested to verify if
GOLD was able to reproduce the experimental data. For this
validation, we selected the available complex of FP3 with
K11017 inhibitor from the PDB databank (PDB code:
3BWK) [24]. The selection of FP3 structure (PDB code:
3BWK) to establish a docking protocol was based on the
following reasons: (i) FP2 and FP3 are both cysteine pro-
teases of Plasmodium Falciparum and contribute more or
less equally to the digestion of hemoglobin in the food
vacuole [21]; (ii) the superimposition of FP2 (3BPF, chainB)
and FP3 (3BWK, chainA) using DaliLite server [25], mat-
ches 240 a-carbons with an RMSDof 1.1 A˚, a Z score of 38.9
and a sequence of identity of 66% and (iii) FP3 X-ray
structure (3BWK) give us access to the bioactive confor-
mation of one of the peptidyl vinyl sulfones derivatives of
this study (ligand 14). The X-ray FP3 structure presented a
missing residue, the C-terminal GLU243, which was added
with the module Biopolymer in Sybyl X 1.3 molecular
modeling program. We followed exactly the same docking
protocol as used above for FP2 whereas the binding site was
defined as 15A˚ radius from the catalytic residue Cys52.
Ligand alignment method
The quality of the spatial alignment of the ligands is the
most sensitive parameter in 3D-QSAR analyses since the
quality and predictive ability of the model are dependent
on the alignment method. In order to identify the most
efficient alignment approach for this data set, two different
procedures were employed: (i) a receptor-docked align-
ment derived from the structure-based docking algorithm
GOLD and (ii) a ligand-based alignment using the structure
of K11017 derived from the crystal structure 3BWK from
the PDB databank. In the latter, the co-crystallized struc-
ture of K11017 was used as the basic skeleton to build the
remaining compounds by modifying the required substi-
tutions. Partial atomic charges were assigned with the
Gasteiger-Marsili method and energy minimization of each
molecule was then performed employing the Tripos stan-
dard force field while keeping the conformation of the
common structure of peptidyl vinyl sulfones.
CoMFA analysis
The CoMFA fields (steric and electrostatic) were generated
using C sp3 atom with a ?1 charge as probe and calculated
using the standard Tripos force field with a distance-
dependent dielectric constant. The cutoff was set to
30 kcal/mol. To form the basis for a statistical significant
model, the method of partial least-squares (PLS) regression
was used to analyze the inhibitors by correlating variations
in their biological activities with variations in their inter-
action fields. The cross-validation analysis was performed
using the leave-one-out (LOO) method wherein one of the
compounds is removed from the data set and its activity
predicted with the model derived from the remaining
compounds. The optimum number of components, N, used
in the model derivation was chosen from the analysis with
the highest cross-validated coefficient, q2, and lowest
standard error of prediction, SEP. The column filtering was
set at 2.0 kcal/mol to speed up the analysis and to reduce
noise. Finally, the non-cross-validation analysis was per-
formed to calculate conventional non cross-validated
coefficient, r2, using the optimum number of components
obtained from the analysis above. In these analyses, a q2 of
0 represents prediction based on random guessing, a q2 of 1
represents perfectly accurate prediction and a negative q2
represents prediction worse than random guessing. Gener-
ally, a minimum q2 of 0.3 is recommended and a QSAR
model with a value of q2[ 0.5 is normally considered to
possess significant predictive ability [26]. However, during
the past few years, evidences have been indicative that q2
appears to be necessary but not a sufficient condition for
the model to have a high predictive power [27, 28]. This
way, it has been proposed the validation on a sufficiently
large test set (*25–33% of total data set) to establish a
reliable 3D-QSAR model [29]. Therefore, the panel com-
prising 39 compounds was split into a training set (30
compounds) and a test set (9 compounds, displayed with an
asterisk in Table 1). The selection of these 9 compounds
was made on the basis that the test set must represent
structural diversity and a range of biological activities
similar to that of the training set. A predictive r square
(rpred
2 ) value was then obtained with the following equation:
r2pred ¼ ðSDÿ PRESSÞ=SD
In the previous expression, SD is the sum of squared
deviation between the biological activities and the mean
activity of the test set molecules and PRESS represents the
sum of squared deviations between the experimental and
predicted activities of the test set compounds.
CoMSIA analysis
CoMSIA similarity indices [30], between the compounds
of interest and the probe atom, were calculated at each
lattice intersection of a regularly spaced grid of 2.0 A˚,
taking the same aligned molecules and the same lattice box
that were used for CoMFA. A probe atom with radius 1.0 A˚
and ?1.0 charge with hydrophobicity of ?1.0 and
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hydrogen bond donor and hydrogen bond acceptor prop-
erties of ?1.0 was used to calculate steric, electrostatic,
hydrophobic, donor and acceptor fields. Gaussian type
distance dependence and the default value of the attenua-
tion factor (a = 0.3) were used.
Results and discussion
The experimental results cover a wide range of pIC50 from
6.456 to 9.155 (calculated from IC50 values in M units)
giving us useful information to understand the different
activity profiles of the molecules in our dataset.
Docking results
Docking accuracy was validated using the known X-ray
structure of FP3 in complex with ligand 14. The ligand was
docked into the binding site of FP3 and the docked confor-
mation corresponding to the highest GoldScore value was
selected as themost likely binding conformation. TheRMSD
between predicted and experimental poses of ligand 14 was
found to be 1.36 A˚, which was quite satisfactory considering
the number of rotatable bonds of the molecule (Fig. 3).
Subsequent docking of ligand 14 in FP2 active site
reproduced the group arrangements into S1–S3 substrate
binding sites (Fig. 4a). Moreover, H-bonds of ligand 14
with Gly92, Asn182, His183, and Trp215 of FP3 binding
site were reproduced in the FP2 active site: Gly83, Asn173,
His174 and Trp206, respectively (Fig. 4b). Although the
ligand adopt similar conformations in each complex, i.e.,
same groups fit into the same substrate binding sites, in the
FP2 ligand 14 complex the conserved phenyl sulfone group
at the S10 position is flipped about *90° out of the active
site in relation to the FP3 complex.
This situation is analogous to that observed for the X-ray
structure of rhodesain with the same ligand when compared
with that of FP3 [24]. The authors attributed this event to
the substitution of Ala166 in FP3 for the slightly bulky
Met145 in rhodesain, which prevent the phenyl sulfone
substituent from lying flat. Superimposition of the FP3 and
FP2 complexes indicates that a similar substitution could
be at the origin of this phenyl sulfone flip. In fact, the
amino acid equivalent to Ala161 in FP3 is the slightly
bulkier Val152 in FP2, which hinders the phenyl sulfone of
the inhibitor to rest on the floor of the S10 pocket (Fig. 5).
However, we believe that this flipping may be transient,
like for the complex of rhodesain and a vinyl sulfone where
the P10 moiety was modeled at half occupancy in both the
‘‘in’’ and ‘‘out’’ conformations [24].
The docking protocol was then applied to all the pep-
tidyl vinyl sulfone derivatives in order to determine their
likely binding conformations into the active site of FP2. All
of the inhibitors bonded to the active site of FP2 in a
similar conformation to ligand 14 and the common chain of
the structures superimposed rather well. Based on the set of
binding conformations and their alignment, CoMFA and
CoMSIA were performed.
CoMFA model and its predictive power
To explore the effect of different alignment methods on the
predictive ability of the CoMFA model, separate CoMFA
models were built for each alignment scheme.
Model 1 was derived from the docking-based alignment
using the structure-based docking algorithm GOLD. To
obtain a good superimposition of the molecules, the
alignment was improved by manually selecting docking
poses for ligands that showed deviations from it. The set of
top-ranked conformations contained 7 compounds (5, 6,
13, 17, 22, 37 and 38) whose structural features did not
superimpose well with the rest of the inhibitors. For these 7
ligands, conformations with lower scores that aligned with
the majority of the other molecules were selected. An
average decrease of 0.9 in the GOLD fitness score was
observed between the top-ranked conformations and those
presenting better alignment profile. These differences in the
GoldScore can be considered as of minor importance.
Figure 6a illustrates the resulting conformational align-
ment of the 30 compounds taken from the docked con-
formations. Model 2 was built from the ligand-based
alignment, which is represented in Fig. 6b. The partial least
square (PLS) statistics of CoMFA models 1 and 2 are
summarized in Table 2.
Fig. 3 Superimposition of co-crystallized pose (CPK reperesenta-
tion) of ligand 14 and top-ranked docked binding mode (silver) into
FP3 catalytic site. Substrate binding sites S1, S10, S2 and S3 of FP3
are shown
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Model evaluation using the Leave-One-Out (LOO)
cross-validation and external validation methods generated
only moderate satisfactory results. By further checking the
observed activities versus the predicted activities (data not
shown) of the models, it was noted that one of the mole-
cules (ligand 35) had predicted errors close to one unit for
Model 1 and higher for Model 2. This indicates that the
target value for this compound was badly estimated.
Molecules can be outliers for various reasons such as (but
not only) structural uniqueness compared to the other
molecules, experimental data outside the range of the other
molecules, or poor experimental data. In our case, we think
it may be due to the large difference in inhibitory activity
compared with other compounds that show only minor
structural differences (ligands 28–39).
When ligand 35 was treated as outlier and excluded
from the models construction, the new models (Model 3
and 4 derived from receptor-based and ligand-based
alignment, respectively) were clearly improved. The partial
least square (PLS) statistics of the two new CoMFA models
are summarized in Table 3.
For Model 3, we obtained a cross-validated LOO q2 of
0.696 (SEP = 0.478) with three principal components and
a non cross-validated r2 of 0.98 (SEE = 0.121). Model 4,
derived from the ligand-based alignment, gave a slightly
better value of LOO cross-validated q2 of 0.784
(SEP = 0.418) with three principal components and a non
cross-validated r2 of 0.936 (SEE = 0.223). In order to use
these models toward lead optimization, they must have
reasonable extrapolative validity in addition to interpola-
tive accuracy. Subsequently, an external validation was
performed on the test set of 9 compounds outside the
training set to evaluate their predictive ability. All the
compounds were predicted well by the two models. Indeed,
models 3 and 4 gave comparable good predictive
rpred
2 values of 0.755 and 0.768, respectively.
LOO cross-validated value, q2, was introduced to gen-
erate an initial measure of the accuracy of model interpo-
lation. The study suggested that all the derived models had
a good cross-validated correlation (q2[ 0.5). Although the
q2 value of the receptor-based CoMFA model was lower
than the ligand-based model, conventional r2 and F value
were higher, while the SEE was lower.
The different alignments also affected the field contri-
butions of the two models: Model 3 showed a higher
contribution of electrostatic field while we verified the
opposite for Model 4. We consider that this may be due to
the fact that the receptor-docked alignment may provide, in
this case, a better representation for predictive intents,
since the observed variability in the position of the
Fig. 4 a Surface representation
of the substrate binding sites of
FP2 with the top-ranked docked
conformation of ligand 14 and
b Ball and stick representation
showing important FP2 residues
that establish hydrogen bonds
with docked ligand 14 (thicker
conformation)
Fig. 5 Phenyl sulfone flipping in the FP2 ligand 14 complex: ribbon
representation of FP3 (green) and FP2 (orange) are shown. Docked
ligand 14, Val152 and Ala161 are colored as their respective enzyme
partners
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different ligands symbolizes the receptor’s ability to dif-
ferently accommodate (up to a point) compounds with
substituents of varying size and electrostatic features. As a
result, receptor-based alignment seems to provide addi-
tional information compared with the ligand-based method.
In addition, the cross-validated PLS analysis indicated that
the CoMFA model derived from the receptor-based align-
ment is robust in predicting both the training and test set and
was then selected for further structural analysis. For the
selected model, the relative contributions of steric and
electrostatic fields for CoMFA correspond to 40 and 60%,
respectively. Electrostatic interactions of molecules from
our dataset with active site of FP2 were found to be a slightly
more influent factor for inhibitory activity. The predicted
inhibitory activity (pIC50) and the residual values for the
training set and the test set, using the developed CoMFA
Model 3, are described in Table 1, while the graphical plot
between the experimental vs predicted FP2 inhibitory
activity for both training and test set is shown in Fig. 7.
CoMSIA model and its predictive power
Taking the same alignment method, training and test set
that were used to derive the best CoMFA model, various
CoMSIA models were generated considering all possible
combinations of CoMSIA field descriptors, i.e., steric (S),
electrostatic (E), hydrophobic (H), hydrogen bond donor
(D) and acceptor (A) fields. The partial least square (PLS)
statistics of all the CoMSIA models are summarized in
Table 4.
Based on the cross-validated and conventional correla-
tion coefficients, q2 and r2, the PLS analyses yielded con-
sistent results of high statistical significance for 11 models
(highlighted in bold, Table 4). The q2 and r2 values of
these models range from 0.651 to 0.754 and 0.956 to 0.998,
respectively. However, on further validation of these ele-
ven best CoMSIA models with respect to their ability to
explain the activity variation among the test set of 9
compounds covering almost the same range of FP2 inhib-
itory activity, only models EH and SEH represented the
best results with a predictive rpred
2 of 0.74 and 0.77,
respectively. The combination of electrostatic and hydro-
phobic fields in CoMSIA gave the best results (Model EH),
giving cross-validation correlation coefficient q2 of 0.711,
conventional correlation coefficient r2 of 0.992 and
Fig. 6 Receptor-based (a) and
ligand-based (b) alignments
used to derive CoMFA models
Table 2 Summary of CoMFA statistical results for the different
alignment methods
QSAR
parametera
Model 1 (receptor-
based alignment)
Model 2 (ligand-
based alignment)
q2 0.604 0.563
N 2 3
SEP 0.559 0.625
r2 0.906 0.845
SEE 0.272 0.358
F test value 130.18 47.187
rpred
2 0.68 0.63
a q2 cross-validated coefficient, N number of components, SEP
standard error of prediction, r2 conventional non cross-validated
coefficient, SEE standard error of estimation, rpred
2 predictive corre-
lation coefficient
Table 3 Summary of CoMFA statistical results for models 3 and 4
(without outlier) derived from receptor and ligand-based alignment,
respectively
QSAR
parametera
Model 3 (receptor-
based alignment)
Model 4 (ligand-
based alignment)
q2 0.696 0.784
N 3 3
SEP 0.478 0.418
r2 0.980 0.936
SEE 0.121 0.223
F test value 427.861 121.26
rpred
2 0.76 0.77
Field contribution (%)
Steric 40 61
Electrostatic 60 39
a Labels as in Table 2
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predictive correlation coefficient rpred
2 of 0.74. The other
combination of steric, electrostatic and hydrophobic fields
(Model SEH) in CoMSIA also gave statistically significant
models, but exhibited relatively lower q2 and r2 values
compared to Model EH. In terms of descriptors, the only
difference between the two models is the contribution of
the steric field in Model SEH.
Mittal et al. previously concluded that the CoMFA steric
field calculated using the steeper Lennard-Jones potential
tends to perform better than CoMSIA steric field calculated
with Gaussian version, which has a slower and smoother
decrease [31]. Indeed, this is true when comparing pre-
dictive ability of CoMSIA Model SE with the related
selected CoMFA model (Model 3). Although the values of
q2 and r2 are similar for those CoMSIA and CoMFA
models, CoMFA Model 3 clearly demonstrates higher
predictive correlation coefficient, rpred
2 of 0.76 compared
Fig. 7 CoMFA predicted versus experimental pIC50 values. Solid
and open circles represent predictions for the training and test sets,
respectively
Table 4 Summary of partial least-squares statistics for CoMSIA models
QSAR parametera
CoMSIA modelb q2 N SEP r2 SEE F test value Field contribution (%) rpred
2
EA 0.754 8 0.480 0.991 0.092 275.391 68 (E), 32 (A) 0.48
SH 0.564 1 0.550 0.737 0.427 75.848 31 (S), 69 (H)
EH 0.711 7 0.508 0.992 0.084 378.244 61 (E), 39 (H) 0.74
SA 0.672 10 0.585 0.993 0.085 257.12 44 (S), 56 (A) 0.42
SD 0.464 2 0.623 0.789 0.390 48.583 33 (S), 67 (D)
SE 0.697 5 0.499 0.979 0.132 210.748 29 (S), 71 (E) 0.68
HA 0.686 2 0.475 0.895 0.275 110.754 57 (H), 43 (A)
ED 0.660 8 0.565 0.983 0.125 146.627 72 (E), 28 (D) 0.58
DA 0.629 2 0.517 0.824 0.356 60.883 56 (D), 44(A)
HD 0.555 2 0.566 0.803 0.377 52.832 50 (H), 50 (D)
SEA 0.709 8 0.522 0.994 0.075 418.005 16 (S), 58 (E), 26 (A) 0.52
SEH 0.670 4 0.507 0.963 0.171 154.676 18 (S), 52 (E), 30 (H) 0.77
EHA 0.729 10 0.531 0.998 0.046 877.078 46 (E), 33 (H), 21 (A) 0.53
SHA 0.668 2 0.492 0.901 0.267 118.591 23 (S), 42 (H), 35 (A)
SED 0.645 7 0.563 0.986 0.111 213.176 21 (S), 54 (E), 25 (D)
EDA 0.712 9 0.533 0.991 0.096 226.141 53 (E), 21 (D), 26 (A) 0.42
EHD 0.651 7 0.558 0.989 0.098 275.324 49 (E), 31 (H), 20 (D) 0.67
SHD 0.536 1 0.567 0.718 0.443 68.729 14 (S), 45 (H), 41 (D)
SDA 0.630 2 0.516 0.868 0.308 85.784 23 (S), 42 (D), 35 (A)
HDA 0.651 2 0.502 0.865 0.312 83.571 40 (H), 35 (D), 25 (A)
SEHA 0.702 3 0.473 0.956 0.181 181.435 10 (S), 42 (E), 27 (H), 21 (A) 0.53
SEHD 0.628 7 0.576 0.988 0.105 237.846 11 (S), 45 (E), 26 (H), 18 (D)
SEDA 0.667 2 0.49 0.903 0.264 121.512 13 (S), 40 (E), 27 (D), 20 (A)
EHDA 0.678 2 0.482 0.899 0.269 116.065 33 (E), 26 (H), 23 (D), 18 (A)
SHDA 0.629 2 0.517 0.873 0.303 89.394 13 (S), 34 (H), 30 (D), 23 (A)
SEHDA 0.659 2 0.496 0.898 0.271 114.759 10 (S), 30 (E), 23 (H), 21 (D), 16 (A)
a Labels as in Table 2
b E electrostatic, S steric, H hydrophobic, D donor, A acceptor
Models with high statistical significance are highlighted in bold
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with 0.68 for CoMSIA SE model. Hence, we assumed that
the lower values of q2 and r2 for CoMSIA Model SEH
might be similar due to the use of steric molecular field
data as one of the descriptors.
In terms of the statistical results, the CoMSIA EH model
was found to be the best, except for predictive correlation
coefficient rpred
2 that, still, remains statistically significant.
In addition, the CoMSIA contour map for steric field,
issued from Model SEH, also presented similar sized
polyhedra than CoMFA steric contour maps at the same
regions (data not shown). Hence, the Model EH of CoM-
SIA was chosen as a complementary source of information
of the previously selected CoMFA model and was used for
final analysis. The observed and calculated activity values
for the training and test set molecules are given in Table 1,
and the plots of the predicted versus the actual activity
values for the training set and test set are shown in Fig. 8.
Graphical interpretation of the CoMFA
and CoMSIA results
The greatest advantage of CoMFA and CoMSIA is that the
field effect on the compounds property can be viewed as
3D contour plots. In our case, these contour plots are useful
to: (i) identify critical regions where any change in the
steric, electrostatic, and hydrophobic fields may affect the
inhibitory activity, and (ii) highlight the key structural
features required for FP2 inhibitory activity. The CoMSIA
electrostatic contour maps were found to be approximately
identical to the corresponding CoMFA contour maps.
Therefore, the graphical interpretation of the CoMSIA
results will only focus on the CoMSIA hydrophobic con-
tour maps since electrostatic contour maps will be dis-
cussed from the CoMFA analysis.
CoMFA steric contour maps
Figure 9 illustrates the contours of the steric fields, show-
ing in green and in yellow the favored and unfavored bulky
groups, respectively. In order to better understand the steric
field contribution, their corresponding contour maps were
projected on the FP2 active site surface.
Two large sterically favorable contours are reported. The
first is located near the R3 position while the second is sit-
uated aside the R1
0 substituents. These two contours suggest
that there is a requisite for bulky groups in this region for
potent FP2 inhibitory activity. Indeed, those two zones are
highly exposed to solvent (Fig. 9) with enough space to
accommodate bulky substituents that would enhance the
interactions between the ligand and protein surface.
One sterically unfavorable contour is localized at the R2
group, which is docked into the S2 pocket of FP2 catalytic
site. This unfavorable contour represents the limitation of
S2 cavity (Fig. 9) and suggests that the occupation of this
area by a bulky group would have a negative effect on the
FP2 inhibitory activity. It is also associated to this FP2
cavity, a small green contour region, which indicates that
certain bulkiness is favored. Thus, these two contour maps
at the S2 pocket reveal that the substituent could be slightly
bulky in depth but not in length.
Indeed, a comparison between molecules that change
from Leu to hPhe shows that bulky groups (in length) are
not preferred at R2 as can be seen by the activities of
compounds 1, 2, 3 and 4 which are lower than those of
compounds 22, 21, 24 and 23. We also detect two smaller
yellow regions near the S3 pocket, corresponding to
Fig. 8 CoMSIA predicted versus experimental pIC50 values. Solid
and open circles represent predictions for the training and test sets,
respectively
Fig. 9 CoMFA steric maps projected on the Connolly molecular
surface of FP2 substrate binding sites (orange). Sterically favorable
and unfavorable areas are shown in green and yellow, respectively.
Molecule 1 is displayed in purple while molecule 22 is colored by
atom type
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possible steric compression of bulky groups in this area by
FP2 residues Tyr78 and Leu84 (Fig. 9).
CoMFA electrostatic contour maps
In the CoMFA electrostatic contours (Fig. 10), the intro-
duction of electronegative substituents in red regions may
increase the inhibitory activity while in blue regions
decrease the affinity. In order to facilitate electrostatic
fields’ analysis, corresponding contour maps were pro-
jected with some FP2 binding pocket residues.
Two relatively large blue-coloured regions are observed
over R2 backbone and R1 side-chain. This region shows an
area where electropositive charged groups within this
glycine rich region of the binding site enhance FP2
inhibitory activity. Docking calculations permitted to ver-
ify that, indeed, the –NH groups of the peptidic bonds form
hydrogen bonds with the carbonyl groups of FP2 residues:
Gly83, Gly82, and Asn81. However, compounds present-
ing O-(phenyl)Ser at R1 position present modest activity
against FP2 due to the disadvantage of repulsive interac-
tions between the oxygen atom and the carbonyl backbone
of Gly40 (e.g. compounds 2 e 7). Indeed, when we explore
the maps around compound 2 and compare them to those
around compound 7, it is clear that the oxygen atom of R1
substituent falls in a blue region where an increase in
positive charge would enhance the activity of the com-
pounds (Fig. 10).
A third smaller blue contour is noticed at the bottom of
the S2 cavity. This can be explained by the fact that almost
all S2 residues are hydrophobic with the exception of two
polar amino acids, Ser159 andAsp234, that are located at the
end of the cavity. The R2 substituent of our dataset com-
pounds toggles between Leu and hPhe. Although both res-
idues are hydrophobic, Leu shows an electron density lower
than that of hPhe aromatic ring, hence reducing the repulsion
with the electron-rich groups of the two S2 polar residues.
Near the SO2–R1
0 group, a red-coloured region is noticed
and represents a zone where electronegative charged groups
improve the activity. Docking calculations of the dataset
showed that electronegative fragments at this position form
electrostatic interactions with Gln36 and Trp206 side-
chains. This is apparent when comparing molecules that
were identical except for R1
0 substituent, which exhibit a
general rank order of FP2 inhibitory activity: sulfonate
esters[ sulfonamides[ sulfones (e.g. ligands 11, 24 and
37). Furthermore, an electron-donating group at this posi-
tion would increase electron density of R1
0 aryl ring and,
consequently, enhance p–p interactions with Trp206.
Furthermore, a second small red-coloured region is
obtained over the aryl ring of R1
0 substituent. This suggests
that the more electron density is delocalized to this ring, the
more p–p interactions established between side-chain of
Trp206 and the ligand are enhanced. Thus, we hypothesize
that electron donor groups in para-position of vinyl sul-
fonate ester aryl ring are preferred to delocalize electron
density to phenyl and, hence, would increase compound’s
activity. Although FP2 activities for vinyl sulfonate esters
are quite similar, this can be observed with compounds 29
and 32. Indeed, the compounds differ only in the p-sub-
stitution of the aryl ring and the one bearing the strongest
electron-donating group, compound 29 with p-OCH3, has
higher inhibitory activity compared to molecule 32 that has
a p-fluoro substituent.
Close to Tyr78 in the S3 cavity, a third red zone is noted
indicating that electron rich groups at this position would
be preferred for FP2 inhibition. We believe that, this way,
p–p interactions with S3 Tyr78 would be favored. Fig-
ure 11 shows electrostatic contours around compounds 8
and 9 that differ only in the R3 group. We can see that the
aromatic moiety of compound 9 establishing stacking
contact with Tyr78 and, consequently, presents a better
FP2 inhibitory activity than compound 8, which does not
form any sort of p-interactions with the same residue.
CoMSIA hydrophobic contour maps
Regarding CoMSIA hydrophobic contour maps, yellow
regions indicate that hydrophobic groups would be favored
Fig. 10 CoMFA electrostatic field contours shown in red (electro-
negative substituents favored) and blue (electropositive substituents
favored) colors. Some FP2 binding pocket residues are represented in
tinny lines while ligands 2 and 7 are colored by atom type and purple,
respectively
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at these positions while grey regions suggest that hydro-
philic groups would be preferred. We observed two large
yellow regions at S10 and S3 pockets, and one small grey
region also close to the S3 cavity. The mapping of the
hydrophobic contours into the active site of FP2 (Fig. 12)
further explained the CoMSIA hydrophobic maps. The
small grey region is observed at the solvent accessible area
of S3 cavity and indicates that hydrophilic groups would be
favorable at this position. This region also corresponds to a
blue electrostatic contour where electropositive groups are
preferred to establish hydrogen bonds with the backbone
residues of this glycine rich region.
The yellow site existing near S10 pocket coincides with
FP2 residue Trp206, suggesting that p–p stacking interac-
tions between this residue and compound’s aryl moiety are
an important factor to increase FP2 inhibitory activity.
Regarding p–p interactions that our dataset compounds
establishwith this highly conserved residue in the S10 subsite
of clan CA cysteine proteases, it is noteworthy that we
observed a preferential placement of the aryl moiety relative
to Trp206 depending on the R1
0 substituent. Figure 13 rep-
resents the docking conformations of the compounds that
have sulfonate ester (A), sulfonamide (B) and sulfone (C) as
R1
0 substituent. It is clear that sulfonate esters present a high
reproducibility in aryl moiety positioning relative to Trp206,
establishing p–p stacking interactions with this aromatic
amino acid. Regarding sulfonamides, we also verified that
many of these compounds place the arylmoiety in such away
that p–p interactions with Trp206 are best favored. Still,
sulfonamides have greater flexibility in positioning R1
0
substituent compared with sulfonate esters. In relation to
sulfones, we observed for all the compounds the same phenyl
sulfone ‘‘flip out’’ discussed in section ‘‘Docking results’’. In
this ‘‘flip out’’ positioning, the aromatic moiety of sulfones
does not establish stacking interactions with Trp206. Based
on these results, we infer that sulfonamides flexibility at R1
0
position may be due to a similar flipping phenomenon.
However, we reinforce that this flippingmay be transient like
the one observed for the complex of rhodesain with a vinyl
sulfone where the R1
0 moietywasmodeled at half occupancy
in both the ‘‘flip in’’ and ‘‘flip out’’ conformations [24]. Since
the sulfonamides have more degrees of freedom and hence
higher flexibility, it is likely that these compounds have
higher occupancy in the ‘‘flip in’’ conformation than sulf-
ones. Regarding sulfonate esters, R1
0 group flexibility clearly
favors the accommodation of the aryl ring into S10 subsite
and thus the formation of p–p interactions with Trp206. We
believe that R1
0 flexibility is also related to the general rank
order of FP2 inhibitory activity observed when comparing
compounds that only differ on R1
0 substituent, i.e., sulfonate
esters[ sulfonamide[ sulfones.
The second hydrophobic zone, at the S3 cavity, is
detected between Tyr78 and Leu84. Compounds that orient
hydrophobic substituents into this region (e.g. compound
26) would have enhanced FP2 inhibitory activity compar-
atively to molecules that do not accommodate any
Fig. 11 CoMFA electrostatic field contours shown in red (electro-
negative substituents favored) and blue (electropositive substituents
favored) colors. Some FP2 binding pocket residues are represented in
tinny lines while ligands 8 and 9 are colored by atom type and purple,
respectively
Fig. 12 CoMSIA hydrophobic field contours shown in yellow
(hydrophobic substituents favored) and grey (hydrophilic substituents
favored) colors. Some FP2 binding pocket residues and ligand 37 are
represented in tinny lines and capped sticks, respectively
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hydrophobic part of R3 group in this zone (e.g. compound
22), as shown in Fig. 14.
Conclusions
A set of 39 peptidyl vinyl sulfone derivatives was inves-
tigated to relate their FP2 inhibitory activity (IC50 values)
with molecular structure. Using CoMFA and CoMSIA
techniques, stable and predictive 3D-QSAR models with
acceptable q2 values were developed. The best predictions
were obtained for the receptor-docked alignment method
and the predictive ability of these models was verified by
leave-one-out and external validation methods. These
results indicate that the structural alignment of high affinity
binding poses obtained from molecular docking simula-
tions comprises biologically active conformations of the
peptidyl vinyl sulfone derivatives, confirming the validity
and usefulness of the alignment. Besides the effective use
of docking as an alignment method, the docking analysis
also provided a qualitative representation of ligand and
enzyme interactions, which are complementary with
CoMFA and CoMSIA maps, and was then helpful in
characterizing fundamental structural features required for
biological activity. Some of the main features observed are:
• Bulky groups near R3 and R1
0 positions, which are
zones highly exposed to the solvent, would enhance the
interactions between the ligand and protein surface and,
thus, the FP2 inhibitory activity.
• One sterically unfavorable contour is localized at the R2
group, matching the limitation of the binding pocket,
and suggests that bulky groups at this position tend to
decrease biological activity. In addition, two additional
smaller unfavorable regions near S3 pocket are detected,
Fig. 13 Docked conformations
of dataset compounds with
sulfonate esters (a), sulfonamide
(b) and sulfone (c) as R1
0
substituent
Fig. 14 Representation of the CoMSIA hydrophobic contour maps
(code color: yellow, hydrophobic substituents favored; grey, hydro-
philic substituents favored) projected on the docked conformations of
compounds 22 and 26 colored by atom type and beige, respectively
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indicating possible steric constraints for bulky groups in
this area, due to FP2 residues Tyr78 and Leu84.
• Electropositive groups at R2 backbone and R1 side-
chain are preferred to improve FP2 inhibitory activity.
Docking analysis permitted to verify that the –NH
groups of ligands peptidic bonds form hydrogen bonds
with the backbone of FP2 residues: Gly83, Gly82,
Asn81 and Gly40.
• Electronegative groups near the SO2–R1
0 group tend to
increase biological activity by forming electrostatic
interactions with Gln36 and Trp206 side-chains.
• A second small region, where electronegatively
charged groups enhance FP2 inhibitory activity, is
obtained over the aryl ring of R1
0 substituent. Analysis
of the docked conformations suggested that the more
electron density is delocalized to this ring, the more p–
p interactions established between the side-chain of
Trp206 and the ligand are improved.
• Compounds that orient any hydrophobic part of R3
group towards Tyr78 and Leu84 would exhibit
enhanced FP2 inhibitory activity.
• Based on docking analysis, R1
0 flexibility was related to
biological activity depending on whether or not it favors
the positioning of the aryl ring in such away it can establish
hydrophobic interactions with Trp206. The general rank
order of FP2 inhibitory activity observed when comparing
compounds that only differ on R1
0 substituent was:
sulfonate esters[ sulfonamide[ sulfones.
In summary, the present work is the first study based on
3D-QSAR and docking simulations for peptidyl vinyl
sulfone derivatives as Pf falcipain inhibitors. The physi-
cochemical meaning of the descriptors of the proposed
models and the characterization of some ligand–protein
interactions provide us valuable guidelines for future
structural modifications of this class of compounds towards
the design of potent antimalarials.
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